Apostolia Tsimberidou

Apostolia Tsimberidou is a Professor of Medicine in the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center. Her research focuses on precision oncology, early-phase clinical trials, and cancer immunotherapy, with recent work examining DNA and RNA profiling concordance, DNA repair pathway alterations, and the impact of severe liver metastases on immunotherapy response. She has also investigated telemedicine’s role in expanding trial access and the convergence of artificial intelligence and machine learning in precision oncology, alongside nanotechnology approaches for solid tumor treatment. Her recent publications appear in npj Precision Oncology, Signal Transduction and Targeted Therapy, and npj Digital Medicine.